1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow OTOF protein, human: new trials by email Literature Review of OTOF protein, human trials Research Report on OTOF protein, human
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations DB-OTO - Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF) | Phase 1 / Phase 2 | Recruiting | Regeneron Pharmaceuticals | 36 | 2023-06-27 | 2026-08-05 |
Auditory neuropathy (1) · Deafness, Autosomal Recessive 9 (1) · Hearing Disorders (1) · Hearing Loss (1) · Hearing Loss, Sensorineural (1)
Germany (1) · Japan (1) · Spain (1) · United Kingdom (1) · United States (1)